Prescribing syringes to prevent HIV: A survey of infectious disease and addiction medicine physicians in Rhode Island

Substance Use and Misuse

Volumn 36, Issue 5, 2001, Pages 535-550

  Rich, Josiah D ^a   Whitlock, Tom L ^a   Towe, Christopher W ^a   McKenzie, Michelle ^a   Runarsdottir, Valgerdur ^a   Aboagye Kumi, Moses ^a   Burris, Scott ^b  

^a BROWN UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Harm reduction; HIV AIDS; Injection drug users; Prescription; Syringe

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; LEGAL ASPECT; MALE; MEDICAL SPECIALIST; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SYRINGE; UNITED STATES;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; COMMUNICABLE DISEASES; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, NON-DRUG; RHODE ISLAND; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; SYRINGES;

EID: 0034970557     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.1081/JA-100103559     Document Type: Article

References (29)

1. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas
2. Hepatitis in used syringes: The limits of sensitivity of techniques to detect hepatitis B Virus (HBV) DNA, hepatitis C Virus (HCV) RNA, and antibodies to HBV core and HCV antigens
3. Injecting behaviors and prevalence of hepatitis B, C, and D markers in New Zealand injecting drug user populations
4. Seroprevalence and risk factors associated with HTLV I/II infection in injection drug users in Northern New Jersey
5. Incidence and risk factors for human T-lymphotropic virus type II (HTLV-II) seroconversion among injecting drug users in Baltimore, Maryland
6. Medical care for injection-drug users with human immunodeficiency virus infection
7. Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States metropolitan areas
8. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment
9. Copping, running, and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver
10. Update: Syringe-exchange programs - United States, 1996
11. Syringe use and reuse: Effects of syringe exchange programs in four cities
12. Effectiveness of needle-exchange programs for prevention of HIV infection
13. Syringe and needle exchange as HIV/AIDS prevention for injection drug users
14. Three years of needle exchange in New Haven: What have we learned?
15. Impact of increased legal access to needles and syringes on practices of injection-drug users and police officers - Connecticut, 1992-1993
16. Human immunodeficiency virus infection in diabetic intravenous drug users
17. Physician prescription of sterile injection equipment: Time for action
18. Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users
19. Infections (Excluding AIDS) in injection drug users
20. Drug abuse treatment success among needle exchange participants
21. HIV incidence among injecting drug users in New York City syringe exchange programs
22. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program
23. AIDS associated with injecting-drug use - United States 1995